| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Centre d’étude du sommeil (Dr. Montplaisir, A. Desautels, and B. Adam), Hôpital du Sacré-C
ur de Montréal and Centre de recherche en sciences neurologiques, Université de Montréal; Research Center (Drs. Turecki and Rouleau, A. Desautels, and A. Sequeira), Douglas Hospital, McGill University; and Centre for Research in Neurosciences (Dr. Rouleau and K. Brisebois), The Montreal General Hospital, McGill University, Québec, Canada.
Address correspondence and reprint requests to Dr. Guy A. Rouleau, Centre for Research in Neurosciences, The Montreal General Hospital, 1650 Cedar Avenue, Montréal, Québec H3G 1A4, Canada; e-mail: mi32{at}musica.mcgill.ca
Background: Impairment in the central dopaminergic system has been consistently suggested as an etiologic factor in restless legs syndrome (RLS).
Objective: To investigate a possible role for the MAOA and MAOB genes in RLS using a population-based association study.
Methods: In addition to a dinucleotide repeat located within the second intron of the MAOB gene, a functional variable number of tandem repeat (VNTR) polymorphism recently identified in the MAOA gene promoter region was examined, using 96 extensively characterized patients and 200 control subjects matched for ethnic background. The relationship between variation at these loci and several clinical features was also considered.
Results: Pertaining to the MAOA gene, females with the high activity allele had a greater risk (OR: 2.0; 95% CI: 1.06 to 3.77) of being affected with RLS than females carrying the low activity alleles. The authors did not observe this association among the male subjects (OR: 0.98; 95% CI: 0.31 to 3.14). Interestingly, females carrying the high transcription alleles showed a longer sleep onset latency (U = 163.5; p = 0.015) and exhibited a higher movement index during the Suggested Immobilization Test (Student’s t-test = -2.02; p = 0.048). No differences were observed regarding the MAOB gene in our sample.
Conclusions: The high activity allele of the MAOA gene may represent a modifying factor involved in the severity of RLS manifestations in females.
This article has been cited by other articles:
|
|
 |
|
  N. G. Cuellar and S. J. Ratcliffe Restless Legs Syndrome in Type 2 Diabetes: Implications to Diabetes Educators The Diabetes Educator, March 1, 2008; 34(2): 218 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Dhawan, M Ali, and K R Chaudhuri Genetic aspects of restless legs syndrome. Postgrad. Med. J., October 1, 2006; 82(972): 626 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Clemens, D. Rye, and S. Hochman Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology, July 11, 2006; 67(1): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tison, A. Crochard, D. Leger, S. Bouee, E. Lainey, and A. El Hasnaoui Epidemiology of restless legs syndrome in French adults: A nationwide survey: The INSTANT Study Neurology, July 26, 2005; 65(2): 239 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Stiasny-Kolster, W. Magerl, W. H. Oertel, J. C. Moller, and R.-D. Treede Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome Brain, April 1, 2004; 127(4): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Borreguero, P. Odin, and C. Serrano Restless legs syndrome and PD: A review of the evidence for a possible association Neurology, September 23, 2003; 61(90063): S49 - 55. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
